GET THE APP

Clinical utility of circulating tumour DNA among patients with lymphoma

Journal of Blood Research & Hematologic Diseases

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Clinical utility of circulating tumour DNA among patients with lymphoma

Lymphoma has been described as the most common haematological malignancy (Chetan et al., 2014) world-wide. In Nigeria precise frequency of cancers, generally, is difficult, owing to the health-seeking behavior of many patients that is oriented toward alternative traditional medicine with attendant loss of data. Nevertheless, in a hospital-based study in Zaria, demonstrated that lymphoma ranked 5th in the list of all histologically-diagnosed cancers in Zaria (Rafindadi et al 2016). It has been shown that liquid biopsies of ct DNA can be effective when needle biopsies prove difficult, e.g. in isolated central nervous system disease or mediastinal diseases (Roschewski M et al., 2015, Kurtz et al 2015, Wang et al., 2015).

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations